Not Yet Recruiting CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation NCT06986434 Conditions Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more Locations the Fifth Medical Center of Chinese People's Liberation Army General Hospital — Beijing, China View Trial Details
